More than 130 suppliers

In-house tech support

Call +31 (0)26 326 44 50

Bio-Connect

Products
Products
Antibodies
Chemicals
Proteins / Signaling Molecules
Assays
DNA / RNA / Vectors
Cell Culture
Genome Editing and Engineering
Molecular Biology
Lysates / Extracts
Expression
Labware / Accesories
Body Products
Technique Specific Products
Arrays / Slides
Promotions
All product groups
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
Suppliers
Industries
Industries
Biotech, Pharma & CRO
Academia
Diagnostics
Environment
Food
Veterinary
All industries
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
News

Website
Tech support
About us
About us
Our company
Our team
Divisions
Vacatures
Events
Promotions
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
FAQ
Contact

ProductsBack/Ranolazine Dihydrochloride [95635-56-6]

Ranolazine Dihydrochloride [95635-56-6]

Research Use Only

R0154

Estimated Purity≥98%

Product group Chemicals

Overview

Supplier
LKT Laboratories
Product Name
Ranolazine Dihydrochloride [95635-56-6]
Delivery Days Customer
7
Certification
Research Use Only
Estimated Purity
≥98%
Format
Soluble in water.
Scientific Description
Nav1.7 and Nav1.8 N1+ channel blocker.; RS-43285
Storage Instruction
Ambient
UNSPSC
12352200

References

Tocchetti CG, Carpi A, Coppola C, et al. Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction. Eur J Heart Fail. 2014 Jan 6. [Epub ahead of print]. PMID: 24464789. Aldakkak M, Stowe DF, Camara AK. Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris. Clin Med Insights Ther. 2013 Jan 15;2013(5):1-14. PMID: 24574825. Aidonidis I, Doulas K, Hatziefthimiou A, et al. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits. J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):94-101. PMID: 22872232.